Equitec Proprietary Markets’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,200
Closed -$99.4K 65
2024
Q3
$99.4K Sell
12,200
-4,612
-27% -$46.2K 0.91% 29
2024
Q2
$225K Hold
16,812
1.71% 28
2024
Q1
$780K Sell
16,812
-44,003
-72% -$2.28M 1.38% 24
2023
Q4
$4.11M Sell
60,815
-2,387
-4% -$146K 4.45% 9
2023
Q3
$4.58M Sell
63,202
-16,813
-21% -$1.34M 4.6% 15
2023
Q2
$5.95M Sell
80,015
-11,126
-12% -$659K 4.21% 15
2023
Q1
$4.85M Sell
91,141
-10,895
-11% -$690K 4.59% 11
2022
Q4
$6.9M Buy
102,036
+44,879
+79% +$4.13M 4.04% 15
2022
Q3
$7.13M Sell
57,157
-4,282
-7% -$510K 3.16% 14
2022
Q2
$5.85M Buy
61,439
+19,878
+48% +$2.42M 2.75% 15
2022
Q1
$6.7M Buy
41,561
+39,575
+1,993% +$7.7M 3.27% 12
2021
Q4
$660K Buy
+1,986
New +$943K 0.35% 71

Other funds holding DNA